Motley Fool: 3 Popular Marijuana Stocks With Surprisingly Poor Margins

According to a newly released report from the duo of Arcview Market Research and BDS Analytics titled “State of the Legal Cannabis Markets,” global cannabis sales could grow in excess of 24% per year through 2024. After registering $10.9 billion…

Advertisements

Motley Fool: Downstream Merger Monday

On today’s episode of MarketFoolery, analysts Jason Moser and Emily Flippen take a look at some market headlines. Two huge defense companies are mergingin a massive deal, but United Technologies (NYSE:UTX) won’t necessarily be as anticompetitive as some current U.S. presidents…

Motley Fool: Is Tilray Finally a Buy?

Canada’s top pot producers have all seen their valuations shoot higher this year — that is, except Tilray (NASDAQ:TLRY). Over the first five months of the year, Tilray’s market cap has slipped by an unsightly 25%. Worse still, the company’s…

Motley Fool: Why Marijuana Stocks Tilray, Cronos, and New Age Beverages Fell 10% to 19% in March

What happened Shares of cannabis companies Tilray (NASDAQ:TLRY), Cronos Group (NASDAQ:CRON), and New Age Beverages (NASDAQ:NBEV) dropped 19.4%, 14.8%, and 10.4%, respectively, in March, according to data from S&P Global Market Intelligence. For context, the S&P 500 rose 1.9% last month. Those stocks have…

Motley Fool: Is the Marijuana Market Opportunity Legit?

Marijuana is one of the most exciting emerging industries for investors right now, but a lot of that excitement could be misplaced. The potential to profit from marijuana stocks will depend significantly upon cooperative governments and willing consumers, and not…